Tunisia: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Tunisia

In 2022, the Tunisian market for other medicaments for therapeutic or prophylactic uses increased by X% to $X, rising for the fourth consecutive year after three years of decline. In general, consumption, however, saw a abrupt decrease. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Tunisia

In value terms, production of other medicaments for therapeutic or prophylactic uses surged to $X in 2022 estimated in export price. Over the period under review, production saw a resilient expansion. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. As a result, production reached the peak level of $X. From 2021 to 2022, production of growth remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Tunisia

In 2022, the amount of other medicaments for therapeutic or prophylactic uses exported from Tunisia contracted dramatically to X tons, with a decrease of X% on the year before. Over the period under review, exports continue to indicate a significant curtailment. The pace of growth was the most pronounced in 2020 with an increase of X% against the previous year. The exports peaked at X tons in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses reduced notably to $X in 2022. In general, exports saw a precipitous descent. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. Over the period under review, the exports of hit record highs at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

Exports by Country

Senegal (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Tunisia, accounting for a approx. X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Senegal totaled X%.

In value terms, Senegal ($X) emerged as the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Tunisia.

From 2012 to 2022, the average annual rate of growth in terms of value to Senegal totaled X%.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, falling by X% against the previous year. Over the period under review, the export price saw a abrupt setback. The growth pace was the most rapid in 2017 when the average export price increased by X%. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Senegal.

From 2012 to 2022, the rate of growth in terms of prices for Libya amounted to X% per year.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Tunisia

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after two years of decline. Overall, imports, however, showed a abrupt descent. Over the period under review, imports of attained the peak figure at X tons in 2012; however, from 2013 to 2022, imports remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses rose significantly to $X in 2022. In general, imports, however, continue to indicate a relatively flat trend pattern. Over the period under review, imports of reached the peak figure at $X in 2013; however, from 2014 to 2022, imports remained at a lower figure.

Imports by Country

France (X tons), Ireland (X tons) and China (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Tunisia, with a combined X% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by China (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Tunisia, comprising X% of total imports. The second position in the ranking was held by France ($X), with a X% share of total imports. It was followed by Switzerland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Germany stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: France (X% per year) and Switzerland (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, with an increase of X% against the previous year. Over the period under review, the import price saw buoyant growth. The most prominent rate of growth was recorded in 2013 when the average import price increased by X% against the previous year. Over the period under review, average import prices hit record highs in 2022 and is likely to see gradual growth in the near future.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Switzerland ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform